First human tests begin for experimental HIV antibody treatment
NCT ID NCT06652958
Summary
This early-stage study is testing the safety and how the body processes a new antibody called VH4527079 in healthy adults and people living with HIV. Researchers are giving single doses by injection or IV to healthy volunteers, and multiple IV doses to a small group of people with well-controlled HIV. The main goal is to see if the antibody is safe and to measure how long it stays in the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Las Vegas, Nevada, 89113, United States
Conditions
Explore the condition pages connected to this study.